Evogene Stock Price on November 24, 2024
| EVGN Stock | USD 1.62 0.02 1.25% |
Below is the normalized historical share price chart for Evogene extending back to March 05, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Evogene stands at 1.62, as last reported on the 24th of November, with the highest price reaching 1.67 and the lowest price hitting 1.52 during the day.
If you're considering investing in Evogene Stock, it is important to understand the factors that can impact its price. Evogene secures Sharpe Ratio (or Efficiency) of -0.21, which denotes the company had a -0.21% return per unit of risk over the last 3 months. Evogene exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evogene's Mean Deviation of 3.83, variance of 28.16, and Standard Deviation of 5.31 to check the risk estimate we provide.
At this time, Evogene's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 24th of November 2024, Stock Based Compensation is likely to grow to about 2 M, while Common Stock Shares Outstanding is likely to drop about 4.3 M. . As of the 24th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.60, while Price To Sales Ratio is likely to drop 63.47. Evogene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of March 2008 | 200 Day MA 5.443 | 50 Day MA 2.372 | Beta 1.084 |
Evogene |
Sharpe Ratio = -0.2142
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EVGN |
Estimated Market Risk
| 5.14 actual daily | 45 55% of assets are more volatile |
Expected Return
| -1.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Evogene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evogene by adding Evogene to a well-diversified portfolio.
Price Book 2.834 | Enterprise Value Ebitda (0.81) | Price Sales 0.9215 | Shares Float 4.7 M | Wall Street Target Price 10 |
Evogene Valuation on November 24, 2024
It is possible to determine the worth of Evogene on a given historical date. On November 24, 2024 Evogene was worth 1.59 at the beginning of the trading date compared to the closed value of 1.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Evogene stock. Still, in general, we apply an absolute valuation method to find Evogene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evogene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Evogene's related companies.
| Open | High | Low | Close | Volume | |
| 1.59 | 1.67 | 1.52 | 1.62 | 71,270 | |
11/24/2024 | 1.59 | 1.67 | 1.52 | 1.62 | 0.00 |
| Backtest Evogene | | | Evogene History | | | Evogene Valuation | Previous |
Evogene Trading Date Momentum on November 24, 2024
| On November 24 2024 Evogene was traded for 1.62 at the closing time. The top price for the day was 1.67 and the lowest listed price was 1.52 . There was no trading activity during the period 0.0. Lack of trading volume on November 24, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.85% . |
Evogene Fundamentals Correlations and Trends
By evaluating Evogene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Evogene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Evogene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Evogene Stock history
Evogene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Evogene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Evogene will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Evogene stock prices may prove useful in developing a viable investing in Evogene
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.6 M | 4.3 M | |
| Net Loss | -24 M | -25.2 M |
Evogene Quarterly Net Working Capital |
|
Evogene Stock Technical Analysis
Evogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Evogene Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Evogene cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Evogene November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Evogene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evogene shares will generate the highest return on investment. By undertsting and applying Evogene stock market strength indicators, traders can identify Evogene entry and exit signals to maximize returns
Evogene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Evogene's price direction in advance. Along with the technical and fundamental analysis of Evogene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Evogene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.12) | |||
| Total Risk Alpha | (1.89) | |||
| Treynor Ratio | (1.98) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.84) | Revenue Per Share 1.881 | Quarterly Revenue Growth 0.398 | Return On Assets (0.28) | Return On Equity (0.82) |
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.